Lisicki Robert — SEC insider filings

SEC reporting owner CIK 1779614. 18 insider filings on record with FilingPulse; latest filed 2026-11-04.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2020-08-06 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ARENA PHARMACEUTICALS INC (ARNA)EVP, Chief Commercial Officer10—10 legs · 68,872 sh · $4,587,92224
Zura Bio Ltd (ZURA)Chief Executive Officer, Director4——4
Cadrenal Therapeutics, Inc. (CVKD)Director3——3
Arcutis Biotherapeutics, Inc. (ARQT)EVP, Chief Commercial Officer1———

Insider filings — Lisicki Robert

FiledFormIssuerReported transactionsSource
2026-11-043Arcutis Biotherapeutics, Inc. (ARQT)Holdings only — no transactions reportedEDGAR
2025-03-034Zura Bio Ltd (ZURA)Grant/award (A): 1,153,000 (derivative) @ $0EDGAR
2025-01-244Cadrenal Therapeutics, Inc. (CVKD)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2024-12-114Zura Bio Ltd (ZURA)Grant/award (A): 117,000 (derivative) @ $0EDGAR
2024-06-214Zura Bio Ltd (ZURA)Grant/award (A): 1,050,000 (derivative) @ $0EDGAR
2024-01-264Zura Bio Ltd (ZURA)Grant/award (A): 1,000,000 (derivative) @ $0EDGAR
2024-01-194Cadrenal Therapeutics, Inc. (CVKD)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2023-07-244Cadrenal Therapeutics, Inc. (CVKD)Grant/award (A): 75,000 (derivative) @ $0EDGAR
2022-03-114ARENA PHARMACEUTICALS INC (ARNA)Other (J): 9,441 · Other (J): 6,660 · Other (J): 21,462 · Disposition to issuer (D): 110,000 (derivative) · Disposition to issuer (D): 75,000 (derivative) · Disposition to issuer (D): 70,000 (derivative) · +2 moreEDGAR
2022-01-054ARENA PHARMACEUTICALS INC (ARNA)Grant/award (A): 21,462 @ $0EDGAR
2021-08-054ARENA PHARMACEUTICALS INC (ARNA)Option exercise (M): 17,500 @ $40.95 · Sale (S): 5,605 @ $59.84 · Sale (S): 11,895 @ $60.20 · Option exercise (M): 17,500 (derivative) @ $0EDGAR
2021-03-034ARENA PHARMACEUTICALS INC (ARNA)Grant/award (A): 6,660 @ $0 · Grant/award (A): 38,850 (derivative) @ $0 · Grant/award (A): 15,200 (derivative) @ $0EDGAR
2021-02-044/AARENA PHARMACEUTICALS INC (ARNA)Holdings only — no transactions reportedEDGAR
2021-02-044ARENA PHARMACEUTICALS INC (ARNA)Option exercise (M): 17,500 @ $40.95 · Sale (S): 1,741 @ $77.70 · Sale (S): 6,400 @ $78.50 · Sale (S): 9,359 @ $79.35 · Option exercise (M): 17,500 (derivative) @ $0EDGAR
2021-01-114ARENA PHARMACEUTICALS INC (ARNA)Option exercise (M): 12,600 @ $0 · Tax withholding (F): 3,159 @ $77.59 · Option exercise (M): 12,600 (derivative) @ $0EDGAR
2020-12-034ARENA PHARMACEUTICALS INC (ARNA)Sale (S): 300 @ $64.87 · Sale (S): 3,022 @ $66.06 · Sale (S): 550 @ $66.72EDGAR
2020-11-304ARENA PHARMACEUTICALS INC (ARNA)Option exercise (M): 6,300 @ $0 · Tax withholding (F): 2,428 @ $65.50 · Option exercise (M): 6,300 (derivative) @ $0EDGAR
2020-08-064ARENA PHARMACEUTICALS INC (ARNA)Option exercise (M): 30,000 @ $40.95 · Sale (S): 7,425 @ $62.63 · Sale (S): 22,575 @ $63.58 · Option exercise (M): 30,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1779614 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs